BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Lotus Eye Hospital And Institute Ltd. Share Price

NSE
BSE

NSE : LOTUSEYE

BSE : 532998

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹101.02

High

₹106.56

Price Summary

Previous Close ₹104.74
Day's Range ₹101.02 - ₹106.56
Open ₹106.56
52 Week Range ₹67.72 - ₹147.00
Volume 7,839
Market Cap ₹0.00
Previous Close ₹104.00
Day's Range ₹101.05 - ₹105.45
Open ₹101.05
52 Week Range ₹68.00 - ₹147.60
Volume 1,143
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 8.21
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 340.77
TTM EPS (₹) 0.31
P/E Ratio 196.62
Book Value(₹) 3.69
PAT Margin (%) 1.49
Face Value (₹) 10.00
ROCE(%) 3.10
Trade Value ( ₹ in Lacs) 1.19
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 340.77
TTM EPS (₹) 0.31
P/E Ratio 196.62
Book Value(₹) 3.69
PAT Margin (%) 1.49
Face Value (₹) 10.00
ROCE(%) 3.10

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 122.47 482.1
Expenses N/A N/A
PBT -4.25 40.14
Operating profit 0.0 0.0
Net profit -2.39 29.14

Shareholding Pattern

Promoters (% Holding)

40.14%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

59.86%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Lotus Eye Hospital And Institute Ltd.

Founded 1997
Managing Director Sangeetha Sundaramoorthy
NSE Symbol LOTUSEYE

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,51,074.97 1,905.20 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,79,485.96 6,818.50 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,49,124.14 4,394.35 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,16,201.01 8,028.70 6,696.50 - 6,696.50
Cipla Ltd. 1,15,640.69 1,426.60 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,11,589.46 1,329.30 1,148.40 - 1,148.40
Lupin Ltd. 1,03,966.32 2,248.00 1,836.80 - 1,836.80
Mankind Pharma Ltd. 1,03,368.09 2,504.00 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 1,02,190.60 1,060.00 903.00 - 903.00
Zydus Lifesciences Ltd. 1,01,755.41 991.20 835.50 - 835.50
no-content No Records Found

Latest News

Apr
18
2026
EQUITY Posted on Apr 18th 2026

Lotus Eye Hospital And Institute informs about updates

Lotus Eye Hospital And Institute has informed that it is not identified as a Large Corporate as on March 31, 2021, as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
17
2026
EQUITY Posted on Mar 17th 2026

Lotus Eye Hospital And Institute informs about outcome of board meeting

Lotus Eye Hospital And Institute has informed that the Board of Directors of the Company, at its meeting held on March 17, 2026 has decided not to proceed with the proposal for voluntary delisting of the Company’s equity shares from National Stock Exchange of India Limited (NSE), considering current market conditions, liquidity factors and the need to ensure continued investor convenience and flexibility. The Company would continue to remain listed on both the stock exchanges, BSE and National Stock Exchange of India. The Board Meeting commenced at 04:30 PM ended at 05:00 PM.
The above information is a part of company’s filings submitted to BSE.
Read More
May
18
2026
EQUITY Posted on May 18th 2026

Laxmi Dental informs about board meeting

Pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Laxmi Dental has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 21, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026. Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in terms of the Code of Conduct for Prevention of Insider Trading of the Company, the trading window for dealing in securities of the Company which was closed from Wednesday, April 01, 2026 for all the designated persons and their immediate relatives shall re-open after the expiry of 48 hours from the date of declaration of the said financial results. The same will be made available on the Company’s website: www.laxmidentallimited.com.
The above information is a part of company’s filings submitted to BSE.
Read More
May
18
2026
EQUITY Posted on May 18th 2026

Hester Biosciences submits secretarial compliance report

Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended time to time, Hester Biosciences has submitted the Annual Secretarial Compliance Report duly signed by Tapan Shah, Practicing Company Secretary, Ahmedabad dated 15 May 2026 for the year ended 31 March 2026. A copy of Annual Secretarial Compliance report enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
May
18
2026
EQUITY Posted on May 18th 2026

Sandu Pharmaceuticals informs about compliance report

Sandu Pharmaceuticals has informed that it enclosed Annual Secretarial Compliance Report for the year ended 31 March 2026 issued by CS Swapnil JDixit, Practising Company Secretary.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Lotus Eye Hospital And Institute Ltd. ?

The current share price of Lotus Eye Hospital And Institute Ltd. is ₹104.74 as of 2026-05-18.

The market capitalisation of Lotus Eye Hospital And Institute Ltd. is ₹222.52 as of 2026-05-15.

The 1-year return of Lotus Eye Hospital And Institute Ltd. is -1.82% as of 2026-05-18.

The P/E ratio of Lotus Eye Hospital And Institute Ltd. is 196.62 as of 2026-05-18.

The 52-week high and low of Lotus Eye Hospital And Institute Ltd. are ₹147.00 and ₹67.72, respectively, as of 2026-05-18.

The dividend yield of Lotus Eye Hospital And Institute Ltd. is 0.0% as of2026-05-15.

You can buy Lotus Eye Hospital And Institute Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Lotus Eye Hospital And Institute Ltd. is Sangeetha Sundaramoorthy.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore